Research Summary
Analyzed using Evidence Intelligence™

Women and frailty linked to poorer adherence in diabetes trial

Key finding

7312 (47.2%) participants were fully adherent to aspirin.

The ASCEND study investigated cardiovascular events in diabetic participants through a randomized controlled trial involving aspirin and omega-3 fatty acid supplementation.

Evidence strength

Moderate confidence

Study type

RCTs

Follow-up

Extended (5–20+ y)

Some Concerns bias
Last updated July 3, 2026

Quick read

Study at a glance

The essential study design details in one scan.

Population

Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes

Intervention

Aspirin, Placebo, Omega-3 Fatty Acid Supplementation, Placebo for Omega-3

Study type

RCTs

Follow-up

Extended (5–20+ y)

Primary outcome

Adherence to Aspirin

Comparator

Placebo for Aspirin, Placebo for Omega-3

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

The ASCEND study investigated cardiovascular events in diabetic participants through a randomized controlled trial involving aspirin and omega-3 fatty acid supplementation.

Clinical relevance

Understanding adherence rates and predictors is crucial for improving treatment strategies in diabetic patients at risk for cardiovascular events. This study highlights the need for targeted interventions to enhance adherence, which can ultimately lead to better health outcomes.

Keep in mind

Effectiveness of interventions remains unclear. Adherence rates may not reflect long-term outcomes. Generalizability may be limited to specific diabetic populations.

Published in

Journal Reference

Publication details and source links for this paper.

Vichithranie WM, Marion M, Georgina B, Louise B, Jane A. ASCEND: A Study of Cardiovascular Events in Diabetes. Trials. 2026;27:183. doi:10.1186/s13063-026-09551-4

Save this study and add notes to your research library.

Main Effects

7312 participants (47.2%) were fully adherent to aspirin.

8937 participants (57.7%) were fully adherent to omega-3.

Adherence decreased with increasing frailty, smoking, and vascular risk score.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Aspirin, Omega-3 Fatty Acid Supplementation and Adherence to aspirin, Treatment adherence, Adherence Predictors for Omega-3, and 1 more.

Primary intervention

Aspirin

Primary outcomes

  • Adherence to aspirin
  • Treatment adherence
  • Adherence Predictors for Omega-3

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

4
Evidence pairs
4
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 63

1

Related topics

4

Evidence pairs

45

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 4 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Core evidence

Study findings

The primary outcomes reported in this study.

StrongIncrease

Adherence to aspirin

Aspirin → Adherence to aspirin

Aspirin → Adherence to aspirin

Evidence profile

StrongIncreaseAdherence & Engagement
Unlock full evidence details
NoneNo Change

Treatment adherence

Aspirin → Treatment adherence

Aspirin → Treatment adherence

Evidence profile

NoneNo ChangeAdherence & Engagement
Unlock full evidence details
NoneNo Change

Adherence Predictors for Omega-3

Omega-3 Fatty Acid Supplementation → Adherence Predictors for Omega-3

Omega-3 Fatty Acid Supplementation → Adherence Predictors for Omega-3

Evidence profile

NoneNo ChangeAdherence & Engagement
Unlock full evidence details
StrongIncrease

Adherence to Omega-3

Omega-3 Fatty Acid Supplementation → Adherence to Omega-3

Omega-3 Fatty Acid Supplementation → Adherence to Omega-3

Evidence profile

StrongIncreaseAdherence & Engagement
Unlock full evidence details

Unlock full evidence analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • 47.2% adherence to aspirin and placebo.
  • 57.7% adherence to omega-3 and its placebo.
  • Adherence predictors included frailty, smoking, and vascular risk.
who this applies

Who this applies to

  • Adults with diabetes.
  • Individuals at risk for cardiovascular events.
keep in mind

Keep in Mind

  • The study's effectiveness findings are unclear.
  • Adherence rates may vary in different populations.
  • Results may not apply to non-diabetic individuals.
between the lines

Between the Lines

  • Effectiveness of interventions remains unclear.
  • Adherence rates may not reflect long-term outcomes.
  • Generalizability may be limited to specific diabetic populations.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Aspirin and Treatment Adherence, Omega-3 Fatty Acid Supplementation and Treatment Adherence.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Aspirin improve adherence to aspirin?

Emerging Evidence

Aspirin appears to improve Adherence to aspirin.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Adherence to aspirin

    EvidenceScore™ Emerging | EvidenceScore™ 55.7 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Omega-3 Fatty Acid Supplementation improve adherence to omega-3?

Emerging Evidence

Omega-3 Fatty Acid Supplementation appears to improve Adherence to Omega-3.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Adherence to Omega-3

    EvidenceScore™ Emerging | EvidenceScore™ 55.7 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Aspirin improve treatment adherence?

Limited Evidence

Current evidence does not show a clear benefit of Aspirin for Treatment adherence.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Treatment adherence

    EvidenceScore™ Limited | EvidenceScore™ 38.1 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Omega-3 Fatty Acid Supplementation improve adherence predictors for omega-3?

Limited Evidence

Current evidence does not show a clear benefit of Omega-3 Fatty Acid Supplementation for Adherence Predictors for Omega-3.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Adherence Predictors for Omega-3

    EvidenceScore™ Limited | EvidenceScore™ 38.1 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.